Episodic Pivots Headlines

Headlines
ARTC | Catalyst: Earnings Report -> ArthroCare Reports Second Quarter 2007 Revenue of $80 Million, EPS of $0.37, Exceeding Consensus Estimates
Float: 28 (mil) Institutional Ownership: 104% Relative Strength: 85
IBD EPS Rtg: 42 Net Profit Margin: 12% ROE: 11%
EPS Growth: 27% (1yr) 50% (3yr)
Sales Growth: 23% (1yr) 30% (3yr)

AXL | Catalyst: Earnings Report -> American Axle quarterly earnings jump 67 percent net income rises 40% EPS $0.64 Per Share
Float: 50 (mil) Institutional Ownership: 102% Relative Strength: 77
IBD EPS Rtg: 74 Net Profit Margin: -7% ROE: -24%
EPS Growth: -503% (1yr) 0% (3yr)
Sales Growth: -6% (1yr) -5% (3yr)

BLG | Catalyst: Earnings Report -> Building Materials shares rally 19% on earnings surprise
Float: 29 (mil) Institutional Ownership: 98% Relative Strength: 7
IBD EPS Rtg: 46 Net Profit Margin: 3% ROE: 13%
EPS Growth: -22% (1yr) 67% (3yr)
Sales Growth: 11% (1yr) 32% (3yr)

BOOM | Catalyst: Earnings Report ->
Float: 12 (mil) Institutional Ownership: 95% Relative Strength: 93
IBD EPS Rtg: 86 Net Profit Margin: 16% ROE: 39%
EPS Growth: 84% (1yr) 135% (3yr)
Sales Growth: 43% (1yr) 47% (3yr)

CALD | Catalyst: Earnings Report -> Callidus Software Q2 loss narrows
Float: 29 (mil) Institutional Ownership: 47% Relative Strength: 95
IBD EPS Rtg: 25 Net Profit Margin: -11% ROE: -16%
EPS Growth: 2% (1yr) 0% (3yr)
Sales Growth: 24% (1yr) 2% (3yr)

CME | Catalyst: Other -> CME Group Reaches New Volume Records
Float: 35 (mil) Institutional Ownership: 82% Relative Strength: 69
IBD EPS Rtg: 94 Net Profit Margin: 38% ROE: 30%
EPS Growth: 32% (1yr) 48% (3yr)
Sales Growth: 23% (1yr) 26% (3yr)

CVTI | Catalyst: Earnings Report -> Rebound from Wednesdays reaction to 2Q Loss
Float: 6 (mil) Institutional Ownership: 67% Relative Strength: 3
IBD EPS Rtg: 10 Net Profit Margin: 0% ROE: -1%
EPS Growth: -125% (1yr) 0% (3yr)
Sales Growth: 6% (1yr) 5% (3yr)

CYMI | Catalyst: Earnings Report -> Cymer 2Q Profit Rises
Float: 35 (mil) Institutional Ownership: 110% Relative Strength: 66
IBD EPS Rtg: 86 Net Profit Margin: 17% ROE: 15%
EPS Growth: 88% (1yr) 0% (3yr)
Sales Growth: 42% (1yr) 27% (3yr)

DECK | Catalyst: Earnings Report -> Deckers Outdoor 2Q Profit Falls but beats forecast
Float: 13 (mil) Institutional Ownership: 109% Relative Strength: 98
IBD EPS Rtg: 87 Net Profit Margin: % ROE: %
EPS Growth: -1% (1yr) 47% (3yr)
Sales Growth: 15% (1yr) 36% (3yr)

GNET | Catalyst: Public Offering -> Global Traffic's offering of 4.5 mln shares priced at $6.25/shr
Float: 9 (mil) Institutional Ownership: 17% Relative Strength: 91
IBD EPS Rtg: 15 Net Profit Margin: -12% ROE: -23%
EPS Growth: -284% (1yr) 0% (3yr)
Sales Growth: 27% (1yr) 0% (3yr)

ICE | Catalyst: Earnings Report -> InterContinental Exchange profit rises 73%
Float: 67 (mil) Institutional Ownership: 75% Relative Strength: 96
IBD EPS Rtg: 96 Net Profit Margin: 45% ROE: 25%
EPS Growth: 712% (1yr) 87% (3yr)
Sales Growth: 101% (1yr) 50% (3yr)

KYPH | Catalyst: Takeover, merger etc -> Medtronic to buy Kyphon for $3.9B
Float: 46 (mil) Institutional Ownership: 120% Relative Strength: 96
IBD EPS Rtg: 88 Net Profit Margin: 2% ROE: 3%
EPS Growth: 30% (1yr) 10% (3yr)
Sales Growth: 33% (1yr) 46% (3yr)

LNCE | Catalyst: Earnings Report -> Lance, Inc. Reports 2007 Second Quarter Net Revenue of $197 Million, Up 5%, and Diluted EPS Increase of 50% to $0.30 from Continuing Operations; Raises Full Year Earnings Estimates
Float: 31 (mil) Institutional Ownership: 72% Relative Strength: 83
IBD EPS Rtg: 82 Net Profit Margin: 3% ROE: 12%
EPS Growth: 3% (1yr) -2% (3yr)
Sales Growth: 12% (1yr) 9% (3yr)

NTY | Catalyst: Earnings Report -> NBTY Inc. Q3 earnings rise
Float: 59 (mil) Institutional Ownership: 93% Relative Strength: 80
IBD EPS Rtg: 90 Net Profit Margin: 9% ROE: 20%
EPS Growth: 43% (1yr) 11% (3yr)
Sales Growth: 8% (1yr) 16% (3yr)

RGNC | Catalyst: Public Offering -> Regency Energy expects $312.5 mln from offering
Float: 12 (mil) Institutional Ownership: 29% Relative Strength: 88
IBD EPS Rtg: 24 Net Profit Margin: 0% ROE: -1%
EPS Growth: 36% (1yr) 0% (3yr)
Sales Growth: 26% (1yr) 0% (3yr)

SRCL | Catalyst: Earnings Report -> Stericycle Q2 earnings rise
Float: 84 (mil) Institutional Ownership: 83% Relative Strength: 91
IBD EPS Rtg: 91 Net Profit Margin: 14% ROE: 19%
EPS Growth: 57% (1yr) 18% (3yr)
Sales Growth: 30% (1yr) 20% (3yr)

SSD | Catalyst: Earnings Report -> Simpson Manufacturing Q2 earnings fall
Float: 37 (mil) Institutional Ownership: 95% Relative Strength: 75
IBD EPS Rtg: 50 Net Profit Margin: 11% ROE: 15%
EPS Growth: 4% (1yr) 20% (3yr)
Sales Growth: 2% (1yr) 16% (3yr)

TRGT | Catalyst: New Contract -> GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disorders
Float: 13 (mil) Institutional Ownership: 25% Relative Strength: 92
IBD EPS Rtg: 49 Net Profit Margin: 9% ROE: 0%
EPS Growth: 96% (1yr) 0% (3yr)
Sales Growth: 2234% (1yr) 124% (3yr)

TUNE | Catalyst: Earnings Report -> Microtune Q2 net income rises
Float: 50 (mil) Institutional Ownership: 45% Relative Strength: 69
IBD EPS Rtg: 51 Net Profit Margin: -9% ROE: -7%
EPS Growth: -108% (1yr) 0% (3yr)
Sales Growth: 21% (1yr) 14% (3yr)

UBH | Catalyst: Takeover, merger etc -> KeyCorp to buy U.S.B. Holding for $24.95-share
Float: 16 (mil) Institutional Ownership: 17% Relative Strength: 72
IBD EPS Rtg: 36 Net Profit Margin: 30% ROE: 14%
EPS Growth: -6% (1yr) 2% (3yr)
Sales Growth: 12% (1yr) 11% (3yr)

WOOF | Catalyst: Earnings Report -> VCA Antech Q2 earnings rise
Float: 82 (mil) Institutional Ownership: 90% Relative Strength: 78
IBD EPS Rtg: 90 Net Profit Margin: 10% ROE: 26%
EPS Growth: 54% (1yr) 33% (3yr)
Sales Growth: 17% (1yr) 22% (3yr)


No headlines
ACA
JADE
SKF